(2S)-2-[4-羟基-3-(3-甲基丁-2-烯基)苯基]-8,8-二甲基-2,3-二氢吡喃并[2,3-f]苯并吡喃-4-酮 | 157414-03-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 中文名称: (2S)-2-[4-羟基-3-(3-甲基丁-2-烯基)苯基]-8,8-二甲基-2,3-二氢吡喃并[2,3-f]苯并吡喃-4-酮
• 英文名称: Shinflavanone
• 英文别名: (2S)-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8,8-dimethyl-2,3-dihydropyrano[2,3-f]chromen-4-one
• CAS: 157414-03-4
• 化学式: C₂₅H₂₆O₄
• 分子量: 390.5
• InChiKey: NEIURIYDQMKXIG-QHCPKHFHSA-N

物化性质

• 沸点：
  582.9±50.0 °C(Predicted)
• 密度：
  1.176±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  29
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Composition for Preventing and/or Treating Metabolic Syndrome and Insulin Resistance Syndrome
  申请人：Tanaka Hozumi

  公开号：US20080188549A1

  公开（公告）日：2008-08-07

  The present invention has its object to provide a specific compound derived from a naturally occurring substance, and a composition for the prevention and/or treatment of metabolic syndrome and insulin resistance syndrome which comprises that as an active ingredient, easily and efficiently. The present invention relates to a composition for the prevention and/or treatment of metabolic syndrome and a composition for the prevention and/or treatment of insulin resistance syndrome, each of which comprises, as an active ingredient, at least one compound selected from among the compound represented by the formula (1), compounds represented by the formula (4) and compounds represented by the formula (5), or a salt or ester thereof.